Vivodyne

Vivodyne is a biotechnology company that accelerates drug discovery by testing drugs on lab-grown three-dimensional human tissues using advanced robotics and artificial intelligence. Its core technology focuses on creating scalable, human-relevant models for preclinical development.

The company's Pipeline V platform provides an end-to-end drug development pipeline, utilizing human organ models to test over 10,000 independent tissues at a time. This approach generates more human data than all clinical trials in the United States combined, with models covering over 20 major organ systems.

Vivodyne has raised $82 million in total funding, including its Series A round, and operates in the United States. It emphasizes ethical solutions to replace animal testing and was recognized as the top 'Small but Mighty' company in Fast Company's World's Most Innovative Companies for 2022.